• ALDH2 Inhibition Triggers Synthetic Lethality in APC-Deficie

  2026-05-20

  The reference study uncovers that inhibiting ALDH2 with disulfiram induces synthetic lethality in APC-deficient colorectal cancer by amplifying ROS and activating the ASK1/JNK apoptotic pathway. This mechanistic insight highlights a targeted vulnerability in colorectal tumors and suggests a promising strategy for overcoming resistance in this genetically defined cancer subtype.

• Brefeldin A in Cell Assays: Protocols, Innovations & Trouble

  2026-05-20

  Brefeldin A (BFA) sets a new benchmark for dissecting ER stress, protein trafficking, and apoptosis mechanisms in cancer research and endothelial injury models. This guide delivers actionable protocols, troubleshooting insights, and translational context, empowering laboratories to achieve reproducibility and mechanistic clarity in even the most challenging cell biology applications.

• Clearing Senescent Beta Cells to Prevent Type 1 Diabetes

  2026-05-19

  Thompson et al. (2019) identified that a subpopulation of pancreatic beta cells in both NOD mice and humans with type 1 diabetes (T1D) becomes senescent and acquires a secretory phenotype contributing to disease progression. The study demonstrates that selective elimination of these senescent beta cells using BCL-2 protein inhibitors prevents T1D onset, suggesting a new therapeutic strategy.

• Machine Learning-Guided Design of LNPs for mRNA Vaccine Deli

  2026-05-19

  This study pioneers the use of machine learning to predict the efficacy of lipid nanoparticle (LNP) formulations for mRNA vaccine delivery, identifying key structural features of ionizable lipids. Experimental validation highlights Dlin-MC3-DMA's superior performance, offering a data-driven framework for streamlined LNP optimization in RNA therapeutics.

• CUDC-907: Technical Guide for Dual PI3K and HDAC Inhibition

  2026-05-18

  CUDC-907 addresses the need for precise dual inhibition of PI3K and HDAC signaling in cancer cell research workflows. It is optimized for in vitro studies requiring coordinated suppression of cell survival, growth, and apoptotic pathways. This compound is not suitable for diagnostic or clinical use and should be handled strictly within research-only protocols.

• PP 1: Unraveling Src Kinase Signaling Complexity in Tumor an

  2026-05-18

  Discover how PP 1, a Src family tyrosine kinase inhibitor, empowers advanced research into cancer and immune signaling dynamics. This cornerstone analysis uniquely integrates multimodal biomarker innovation and practical assay strategies for precision oncology.

• QPRT Drives Breast Cancer Invasion via ROCK-MLC Axis Modulat

  2026-05-17

  This study reveals that quinolinate phosphoribosyltransferase (QPRT) enhances breast cancer cell invasiveness through myosin light chain phosphorylation, implicating ROCK pathway activity. The findings identify QPRT as a potential therapeutic target and clarify how ROCK inhibitors such as Y-27632 dihydrochloride can attenuate cancer cell migration and invasion.

• HotStart™ 2X Green qPCR Master Mix: Precision Tools for Quan

  2026-05-16

  Discover how HotStart 2X Green qPCR Master Mix advances gene expression analysis with antibody-mediated hot-start Taq inhibition and robust SYBR Green chemistry. This article uniquely connects assay precision to emerging insights from ADP-ribosylation research, guiding informed protocol design.

• Field Comparison of UAV and Knapsack Sprayer Pesticide Drift

  2026-05-15

  This study provides the first direct field-scale comparison of pesticide spray drift and deposition using unmanned aerial vehicles (UAVs) and electric knapsack sprayers (EKS), with Rhodamine B as a fluorescent tracer. The findings demonstrate that UAVs produce substantially greater drift distances and deposition rates, offering critical data for environmental risk assessment and regulatory guidance in modern agricultural practice.

• Gramine as a Next-Generation Ferroptosis Tool: Mechanistic D

  2026-05-15

  Explore the unique mechanistic insights and translational value of Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) as a ferroptosis inducer in cancer biology research. This article delivers a comprehensive analysis of its CUL3–MTDH axis targeting and practical assay considerations, setting it apart from existing protocol-focused resources.

• Caspase-3 Fluorometric Assay Kit: Precision Apoptosis Measur

  2026-05-14

  The Caspase-3 Fluorometric Assay Kit empowers researchers to quantify apoptosis with high sensitivity and workflow simplicity, crucial for deciphering complex cell death mechanisms. Integrating insights from RCC cell models, this kit stands out for reproducibility and direct translation to neurodegeneration and oncology research.

• cgSHAPE-seq Maps RNA-Degrader Binding Sites in SARS-CoV-2 5’

  2026-05-14

  Tang et al. introduce cgSHAPE-seq, a chemical-guided sequencing approach that precisely identifies small molecule binding sites within the highly structured 5’ untranslated region (UTR) of the SARS-CoV-2 genome. Their findings inform the rational design of RNA-degrading chimeras targeting conserved viral RNA elements, offering a robust methodology for the development of next-generation antivirals.

• Synergistic Dual OXPHOS Blockade: LRPPRC Inhibition Plus Das

  2026-05-13

  This study demonstrates that combining LRPPRC inhibition with dasatinib achieves robust, synergistic anti-tumor activity by coordinately disrupting mitochondrial and nuclear-encoded OXPHOS gene expression. These findings refine our understanding of tumor metabolic dependencies and inform new, rational combination strategies for targeting LRPPRC-high cancers.

• Technical Guidance: HyperScribe™ T7 High Yield Cy3 RNA Label

  2026-05-13

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus addresses the need for high-yield, fluorescently labeled RNA probes for research workflows such as in situ hybridization and Northern blotting. This kit is not validated for diagnostic or therapeutic applications, and its use should be limited to fluorescence-based RNA detection in research settings.

• Deferasirox Fe3+ Chelate: Mechanistic Insights and Research

  2026-05-12

  Explore the advanced iron chelation mechanism of Deferasirox Fe3+ chelate in chronic anemia models. This article delivers a deep, evidence-based analysis of its molecular action, research applications, and protocol implications—distinct from existing guides.

16725 records 1/1115 page Next 12345 下5页 Last page